Template talk:Health risks in the conjugated estrogens and medroxyprogesterone acetate substudy of the Women's Health Initiative
Appearance
This is the talk page for discussing improvements to the Health risks in the conjugated estrogens and medroxyprogesterone acetate substudy of the Women's Health Initiative redirect. |
|
This redirect does not require a rating on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||
|
Table cell order
[edit]"Absolute Risk per 10,000 Women-Years" probably needs to be placed above "placebo" and "CEEs/MPA" cells to be semantic or more accessible. 84.250.17.211 (talk) 09:33, 27 March 2019 (UTC)
Categories:
- Redirect-Class pharmacology articles
- NA-importance pharmacology articles
- WikiProject Pharmacology articles
- Redirect-Class medicine articles
- NA-importance medicine articles
- All WikiProject Medicine pages
- NA-Class women's health articles
- NA-importance women's health articles
- WikiProject Women's Health articles